TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response

Cell

Volumn 131, Issue 6, 2007, Pages 1124-1136

  Rothlin, Carla V ^a   Ghosh, Sourav ^a   Zuniga, Elina I ^b   Oldstone, Michael B A ^b   Lemke, Greg ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

CYTOKINE RECEPTOR; INTERFERON RECEPTOR; PROTEIN AXL; PROTEIN MER; PROTEIN TYRO3; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UBIQUITINATION;

EID: 36849033963     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2007.10.034     Document Type: Article

References (43)

1. Akira S. TLR signaling. Curr. Top. Microbiol. Immunol. 311 (2006) 1-16
2. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
3. Angelillo-Scherrer A., de Frutos P., Aparicio C., Melis E., Savi P., Lupu F., Arnout J., Dewerchin M., Hoylaerts M., Herbert J., et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat. Med. 7 (2001) 215-221
4. Banchereau J., and Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25 (2006) 383-392
5. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., Du X., and Hoebe K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24 (2006) 353-389
6. Borgel D., Clauser S., Bornstain C., Bieche I., Bissery A., Remones V., Fagon J.Y., Aiach M., and Diehl J.L. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit. Care Med. 34 (2006) 219-222
7. Broad A., Jones D.E., and Kirby J.A. Toll-like receptor (TLR) response tolerance: A key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr. Med. Chem. 13 (2006) 2487-2502
8. Brouwer J.L., Bijl M., Veeger N.J., Kluin-Nelemans H.C., and van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood 104 (2004) 143-148
9. Budagian V., Bulanova E., Orinska Z., Thon L., Mamat U., Bellosta P., Basilico C., Adam D., Paus R., and Bulfone-Paus S. A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control. EMBO J. 24 (2005) 4260-4270
10. Camenisch T.D., Koller B.H., Earp H.S., and Matsushima G.K. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J. Immunol. 162 (1999) 3498-3503
11. Caraux A., Lu Q., Fernandez N., Riou S., Di Santo J.P., Raulet D.H., Lemke G., and Roth C. Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. Nat. Immunol. 7 (2006) 747-754
12. Collins C.E., Gavin A.L., Migone T.S., Hilbert D.M., Nemazee D., and Stohl W. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: Disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels. Arthritis Res. Ther. 8 (2006) R6
13. Dong C., Davis R.J., and Flavell R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 20 (2002) 55-72
14. Frobose H., Ronn S.G., Heding P.E., Mendoza H., Cohen P., Mandrup-Poulsen T., and Billestrup N. Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol. Endocrinol. 20 (2006) 1587-1596
15. Gilchrist M., Thorsson V., Li B., Rust A.G., Korb M., Kennedy K., Hai T., Bolouri H., and Aderem A. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441 (2006) 173-178
16. Hacker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L.C., Wang G.G., Kamps M.P., Raz E., Wagner H., Hacker G., et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439 (2006) 204-207
17. Hanada T., Yoshida H., Kato S., Tanaka K., Masutani K., Tsukada J., Nomura Y., Mimata H., Kubo M., and Yoshimura A. Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity 19 (2003) 437-450
18. Hoffmann A., and Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210 (2006) 171-186
19. Honda K., Takaoka A., and Taniguchi T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25 (2006) 349-360
20. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
21. Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Huber M., Kalis C., Keck S., Galanos C., et al. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6 (2005) 565-570
22. Lai C., and Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 6 (1991) 691-704
23. Lai C., Gore M., and Lemke G. Structure, expression, and activity of Tyro3, a neural adhesion-related receptor tyrosine kinase. Oncogene 9 (1994) 2567-2578
24. Lemke G., and Lu Q. Macrophage regulation by Tyro3 family receptors. Curr. Opin. Immunol. 15 (2003) 31-36
25. Levy D.E., and Darnell Jr. J.E. Stats: Transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3 (2002) 651-662
26. Liew F.Y., Xu D., Brint E.K., and O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5 (2005) 446-458
27. Lu Q., Gore M., Zhang Q., Camenisch T., Boast S., Casagranda F., Lai C., Skinner M.K., Klein R., Matsushima G.K., et al. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature 398 (1999) 723-728
28. Lu Q., and Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro3 family. Science 293 (2001) 306-311
29. Mansell A., Smith R., Doyle S.L., Gray P., Fenner J.E., Crack P.J., Nicholson S.E., Hilton D.J., O'Neill L.A., and Hertzog P.J. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7 (2006) 148-155
30. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6 (2006) 823-835
31. Meesters E.W., Hansen H., Spronk H.M., Hamulyak K., Rosing J., Rowshani A.T., ten Berge I.J., and ten Cate H. The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus. Blood Coagul. Fibrinolysis 18 (2007) 21-28
32. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., and Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 264 (1994) 1918-1921
33. Negishi H., Ohba Y., Yanai H., Takaoka A., Honma K., Yui K., Matsuyama T., Taniguchi T., and Honda K. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. USA 102 (2005) 15989-15994
34. Prasad D., Rothlin C.V., Burrola P., Burstyn-Cohen T., Lu Q., Garcia de Frutos P., and Lemke G. TAM receptor function in the retinal pigment epithelium. Mol. Cell. Neurosci. 33 (2006) 96-108
35. Ruiz-Irastorza G., Khamashta M.A., Castellino G., and Hughes G.R. Systemic lupus erythematosus. Lancet 357 (2001) 1027-1032
36. Scott R.S., McMahon E.J., Pop S.M., Reap E.A., Caricchio R., Cohen P.L., Earp H.S., and Matsushima G.K. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411 (2001) 207-211
37. Sen P., Wallet M.A., Yi Z., Huang Y., Henderson M., Mathews C.E., Earp H.S., Matsushima G., Baldwin Jr. A.S., and Tisch R.M. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood 109 (2007) 653-660
38. Sharif M.N., Sosic D., Rothlin C.V., Kelly E., Lemke G., Olson E.N., and Ivashkiv L.B. Twist mediates suppression of inflammation by type I IFNs and Axl. J. Exp. Med. 203 (2006) 1891-1901
39. Smiley S.T., Boyer S.N., Heeb M.J., Griffin J.H., and Grusby M.J. Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity. Proc. Natl. Acad. Sci. USA 94 (1997) 11484-11489
40. Stitt T.N., Conn G., Gore M., Lai C., Bruno J., Radziejewski C., Mattsson K., Fisher J., Gies D.R., Jones P.F., et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro3/Axl family of receptor tyrosine kinases. Cell 80 (1995) 661-670
41. Wormald S., and Hilton D.J. The negative regulatory roles of suppressor of cytokine signaling proteins in myeloid signaling pathways. Curr. Opin. Hematol. 14 (2007) 9-15
42. Yoshimura A., Nishinakamura H., Matsumura Y., and Hanada T. Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res. Ther. 7 (2005) 100-110
43. Zong C., Yan R., August A., Darnell Jr. J.E., and Hanafusa H. Unique signal transduction of Eyk: Constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J. 15 (1996) 4515-4525